Unique ID issued by UMIN | UMIN000010928 |
---|---|
Receipt number | R000012056 |
Scientific Title | Adipocytokine regulation by antihypertensive drugs in patients with essential hypertension |
Date of disclosure of the study information | 2013/07/01 |
Last modified on | 2019/12/16 15:08:52 |
Adipocytokine regulation by antihypertensive drugs in patients with essential hypertension
Adipocytokine regulation by antihypertensive drugs in patients with essential hypertension
Adipocytokine regulation by antihypertensive drugs in patients with essential hypertension
Adipocytokine regulation by antihypertensive drugs in patients with essential hypertension
Japan |
Hypertension
Cardiology | Endocrinology and Metabolism |
Others
NO
To investigate the regulation of adipocytokines's expression by angiotensin 2 type 1 receptor antagonists and calcium blocker.
Others
To investigate the functional role of angiotensin 2 type 1 receptor blockers (ARBs) in cardiovascular diseases including hypertension via the regulation of adipocytokines.
Exploratory
Explanatory
Not applicable
The plasma levels of adipocytokines (Adiponectin, Omentin, Aedipolin, C1q/TNF-related protein (CTRP)-1,6,9, FAM132B, FSTL-1, C1ORF54, Neuron-derived neurotrophic factor (NDNF)) after 4 months.
Blood pressure
Clinical data
Factorial
Randomized
Individual
Open -no one is blinded
Active
2
Prevention
Medicine |
The hypertensive patients under amlodipine administration are intended for enrolement of this study. The patients are assigned to Group A (amlodipine).
The hypertensive patients under amlodipine administration are intended for enrolement of this study. The patients are assigned to Group B (Olmesartan or Telmisartan). As to Group B, the patiens are assigned to Olmesartan or Telmisartan at random.
20 | years-old | <= |
Not applicable |
Male and Female
The hypertensive patients under amlodipine administration for more than 3 months are intended for enrolement of this study.
1. Age; over 20 years old
2. Clinical data
AST<100IU/L
ALT<100IU/L
Cre<1.5mg/dl
3. Informed consent is needed.
1. The patients under calcium blocker other than amlodipine.
2. Uncontroled hypertensive patients with over 140mmHg (systolic) or 90mmHg (diastolic).
3. The patients with bilateral renal artery stenosis or the patients of 1 kidney with renal artery stenosis.
4. The patients with malignancy needed chemotherapy.
5. The patients who has experienced serious side effects for angiotensin receptor type 1 blocker or calcium blocker.
30
1st name | |
Middle name | |
Last name | Noriyuki Ouchi |
Nagoya Universtiy School of Medicine
Molecular Cardiovascular Medicine
65 Tsurumaicho, Showa-ku, Nagoya, Aichi, Japan
+81-52-744-2147
nouchi@med.nagoya-u.ac.jp
1st name | |
Middle name | |
Last name | Koji Ohashi |
Nagoya University School of Medicine
Molecular Cardiovascular Medicine
65 Tsurumaicho, Showa-ku, Nagoya, Aichi, Japan
+81-52-744-2147
ohashik@med.nagoya-u.ac.jp
Molecular Cardiovascular Medicine, Nagoya University School of Medicine
Molecular Cardiovascular Medicine, Nagoya University School of Medicine
Other
Japan
None
NO
名古屋大学附属病院(愛知県)
2013 | Year | 07 | Month | 01 | Day |
Unpublished
Terminated
2013 | Year | 06 | Month | 11 | Day |
2013 | Year | 06 | Month | 11 | Day |
2013 | Year | 07 | Month | 01 | Day |
2016 | Year | 03 | Month | 31 | Day |
2016 | Year | 12 | Month | 15 | Day |
2016 | Year | 12 | Month | 15 | Day |
2016 | Year | 12 | Month | 15 | Day |
2013 | Year | 06 | Month | 11 | Day |
2019 | Year | 12 | Month | 16 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012056
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |